Freda C Lewis-Hall

CIK 1437909 · Executive Vice President · last filed 2026-03-25

Freda C Lewis-Hall is an Executive Vice President who has filed 150 SEC Form 4 insider transactions across 9 companies since 2008. The most recent filing, for PYXS, was dated Mar 25, 2026. Across all open-market trades the lifetime net is −$310.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $39.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$39.11M

Companies

9

Total Filings

150

Lifetime Open-Market Net

-$310.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PYXS Director 241,405 $1.76 $424.9K $0 6 2026-03-25
CDTTW Director 39,801 $0.01 $502 $0 4 2025-08-26
SpringWorks Therapeutics, Inc. (SWTX) Delisted Director 4,017,245 $46.99 $188.77M $900.0K 9 2025-07-02
CDT Director $0.70 $0 1 2023-12-14
EXACT SCIENCES CORP (EXAS) Delisted Director 19,688 $104.91 $2.07M $0 5 2023-06-12
1Life Healthcare Inc (ONEM) Delisted Director 4,534 $16.47 $74.7K $0 3 2022-06-06
PFE Executive Vice President 468,690 $26.21 $12.28M -$1.10M 113 2019-03-01
THC Director 15,314 $174.66 $2.67M $0 3 2016-05-17
VRTX EVP, Medicines Development 53,334 $444.93 $23.73M -$106.3K 5 2009-03-20

Recent Filings

150 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-25 PYXS Grant (A) $0 EDGAR
2025-08-26 CDTTW Grant (A) +35,000 $0 EDGAR
2025-07-02 SpringWorks Therapeutics, Inc. (SWTX) Delisted Disp (D) −24,727 $0 EDGAR
2025-05-15 SpringWorks Therapeutics, Inc. (SWTX) Delisted Grant (A) +10,060 $0 EDGAR
2025-04-02 PYXS Grant (A) $0 EDGAR
2025-04-01 CDTTW Grant (A) +47,612 $42.4K EDGAR
2024-12-20 CDTTW Grant (A) $0 EDGAR
2024-11-20 CDTTW Grant (A) +437,976 $40.2K EDGAR
2024-05-17 SpringWorks Therapeutics, Inc. (SWTX) Delisted Grant (A) +4,095 $0 EDGAR
2024-03-28 PYXS Grant (A) +35,219 $0 EDGAR
Showing 110 of 150
Page 1 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.